Patent ID: 7825113

Claim:
A method for the treatment of obesity or an obesity-related disorder selected from the group consisting of hyperlipaemia, hyperlipidaemia, hyperglycaemia (type II diabetes), hypertension, cardiovascular disease, stroke, and gastrointestinal disease, the method comprising administering to a subject in need thereof a therapeutically effective amount of a compound of formula (II): or a pharmaceutically acceptable salt, ester or amide thereof, wherein: R 1 is a branched or unbranched alkyl which is optionally interrupted by one or more oxygen atoms, alkenyl, alkynyl, phenyl, phenylalkyl, or a substituted derivative of any of the foregoing groups, wherein the substituents are one or more independently of halogen, alkyl, or —OR 6 , and wherein when R 1 is a branched or unbranched alkyl it can also be optionally substituted with phenyl, thienyl or benzoxazin-4-one, with the proviso that any hetero atom substituent in R 1 must be separated from the exocyclic oxygen atom by at least two carbon atoms; R 6 is alkyl or phenyl; and R 8 , R 9 , R 10 , R 11 are each independently hydrogen, halo, hydroxyl, alkyl, or alkoxy.